Your browser doesn't support javascript.
Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) data contributed by 13,829 respondents to a national survey about COVID-19 restrictions in Australia.
Stocker, Ruby; Tran, Thach; Hammarberg, Karin; Nguyen, Hau; Rowe, Heather; Fisher, Jane.
  • Stocker R; Global and Women's Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Electronic address: ruby.stocker@monash.edu.
  • Tran T; Global and Women's Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Hammarberg K; Global and Women's Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Nguyen H; Global and Women's Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Rowe H; Global and Women's Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Fisher J; Global and Women's Health, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Psychiatry Res ; 298: 113792, 2021 04.
Article in English | MEDLINE | ID: covidwho-1085486
ABSTRACT
While the Patient Health Questionnaire 9 (PHQ-9) and General Anxiety Disorder 7 (GAD-7) are frequently used in mental health research, few studies have reported comprehensive data on these measures from population or community samples. The PHQ-9 and GAD-7 were used as indicators of symptoms of depression and anxiety in a national online anonymous survey to assess the mental health of adults in Australia during the COVID-19 restrictions. The aim of this study was to describe gender- and age-specific PHQ-9 and GAD-7 item and summary data contributed by those who completed this survey. Data were analysed descriptively. Complete survey responses were contributed by 13,829 people. For both measures, item-by-item results, summary statistics (mean, standard deviation, minimum, maximum, median and interquartile range) and prevalence of severity categories are reported for the whole sample, and disaggregated by gender and age groups. These comprehensive data provide a useful point of comparison for future COVID-19-related or other research among population or community samples. Other researchers are encouraged to report detailed PHQ-9 and GAD-7 data in the future, to enable and promote relevant between-group comparisons.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anxiety Disorders / Psychiatric Status Rating Scales / Communicable Disease Control / Depressive Disorder / Patient Health Questionnaire / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: English Journal: Psychiatry Res Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anxiety Disorders / Psychiatric Status Rating Scales / Communicable Disease Control / Depressive Disorder / Patient Health Questionnaire / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Oceania Language: English Journal: Psychiatry Res Year: 2021 Document Type: Article